PULMICORT FLEXHALER
ICS DPI
Budesonide · Cheplapharm (US distribution: Allegis Pharmaceuticals; formerly AstraZeneca)
Active Medication & Mechanism
- Budesonide ICS90 mcg or 180 mcg per actuation (delivers approximately 80 mcg or 160 mcg from the mouthpiece)
Corticosteroid with potent glucocorticoid and weak mineralocorticoid activity. Reduces airway inflammation by inhibiting inflammatory cell recruitment and cytokine production.
FDA-Approved Dosing — Strength × Indication
Strength Regimen Asthma
180 mcg
2 inhalations (360 mcg) twice daily → 720 mcg
FDA Approved
Recommended starting dose for adults; some patients may start at 180 mcg twice daily. Maximum 720 mcg twice daily (1440 mcg/day). The current label has no prior-therapy dose tiers.
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
180 mcg 2 inhalations (360 mcg) twice daily → 720 mcg
Asthma FDA Approved
Recommended starting dose for adults; some patients may start at 180 mcg twice daily. Maximum 720 mcg twice daily (1440 mcg/day). The current label has no prior-therapy dose tiers.
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
Not a rescue inhaler. Not for acute use. Use a SABA.